{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T21:47:04Z","timestamp":1784756824959,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"DOI":"10.1186\/s13104-025-07364-3","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T15:35:45Z","timestamp":1752593745000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Activation of the aryl hydrocarbon receptor with structurally diverse ligands suppresses class switch to immunoglobulin A"],"prefix":"10.1186","volume":"18","author":[{"given":"Alex B.","family":"Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory K.","family":"DeKrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"issue":"17","key":"7364_CR1","doi-asserted-by":"publisher","first-page":"8185","DOI":"10.1073\/pnas.89.17.8185","volume":"89","author":"KM Burbach","year":"1992","unstructured":"Burbach KM, Poland A, Bradfield CA. Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. PNAS. 1992;89(17):8185\u20139. https:\/\/doi.org\/10.1073\/pnas.89.17.8185","journal-title":"PNAS"},{"issue":"1","key":"7364_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/toxsci\/kfr218","volume":"124","author":"MS Denison","year":"2011","unstructured":"Denison MS, Soshilov AA, He G, DeGroot DE, Zhao B. Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the Aryl hydrocarbon (dioxin) receptor. Toxicol Sci. 2011;124(1):1\u201322. https:\/\/doi.org\/10.1093\/toxsci\/kfr218","journal-title":"Toxicol Sci"},{"issue":"3","key":"7364_CR3","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.taap.2007.01.014","volume":"220","author":"M Frericks","year":"2007","unstructured":"Frericks M, Meissner M, Esser C. Microarray analysis of the AHR system: tissue-specific flexibility in signal and target genes. Toxicol Appl Pharmacol. 2007;220(3):320\u201332. https:\/\/doi.org\/10.1016\/j.taap.2007.01.014","journal-title":"Toxicol Appl Pharmacol"},{"key":"7364_CR4","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00281-013-0390-8","volume":"35","author":"DH Sherr","year":"2013","unstructured":"Sherr DH, Monti S. The role of the Aryl hydrocarbon receptor in normal and malignant B cell development. Semin Immunopathol. 2013;35:705\u201316. https:\/\/doi.org\/10.1007\/s00281-013-0390-8","journal-title":"Semin Immunopathol"},{"issue":"2","key":"7364_CR5","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2174\/138920011795016818","volume":"12","author":"L Stejskalova","year":"2011","unstructured":"Stejskalova L, Dvorak Z, Pavek P. Endogenous and exogenous ligands of Aryl hydrocarbon receptor: current state of Art. Curr Drug Metab. 2011;12(2):198\u2013212. https:\/\/doi.org\/10.2174\/138920011795016818","journal-title":"Curr Drug Metab"},{"issue":"1\u20132","key":"7364_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/s0009-2797(97)00111-7","volume":"110","author":"Y Wei","year":"1998","unstructured":"Wei Y, Helleberg H, Rannug U, Rannug A. Rapid and transient induction of CYP1A1 gene expression in human cells by the Tryptophan photoproduct 6-formylindolo [3, 2-b] carbazole. Chem Biol Interact. 1998;110(1\u20132):39\u201355. https:\/\/doi.org\/10.1016\/s0009-2797(97)00111-7","journal-title":"Chem Biol Interact"},{"issue":"1","key":"7364_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/toxsci\/kfq024","volume":"115","author":"BC DiNatale","year":"2010","unstructured":"DiNatale BC, Murray IA, Schroeder JC, Flaveny CA, Lahoti TS, Laurenzana EM, et al. Kynurenic acid is a potent endogenous Aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling. Toxicol Sci. 2010;115(1):89\u201397. https:\/\/doi.org\/10.1093\/toxsci\/kfq024","journal-title":"Toxicol Sci"},{"issue":"1","key":"7364_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1124\/jpet.114.222265","volume":"353","author":"AD Joshi","year":"2015","unstructured":"Joshi AD, Carter DE, Harper TA, Elferink CJ. Aryl hydrocarbon Receptor\u2013Dependent stanniocalcin 2 induction by cinnabarinic acid provides cytoprotection against Endoplasmic reticulum and oxidative stress. J Pharmacol Exp Ther. 2015;353(1):201\u201312. https:\/\/doi.org\/10.1124\/jpet.114.222265","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"7364_CR9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1124\/jpet.112.195339","volume":"343","author":"U Jin","year":"2012","unstructured":"Jin U, Lee S, Safe S. Aryl hydrocarbon receptor (AHR)-active pharmaceuticals are selective AHR modulators in MDA-MB-468 and BT474 breast cancer cells. J Pharmacol Exp Ther. 2012;343(2):333\u201341. https:\/\/doi.org\/10.1124\/jpet.112.195339","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"7364_CR10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1021\/tx7001965","volume":"21","author":"LP Nguyen","year":"2007","unstructured":"Nguyen LP, Bradfield CA. The search for endogenous activators of the Aryl hydrocarbon receptor. Chem Res Toxicol. 2007;21(1):102\u201316. https:\/\/doi.org\/10.1021\/tx7001965","journal-title":"Chem Res Toxicol"},{"issue":"1","key":"7364_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.taap.2013.01.015","volume":"268","author":"Q Zhang","year":"2013","unstructured":"Zhang Q, Kline DE, Bhattacharya S, Crawford RB, Conolly RB, Thomas RS, et al. All-or-none suppression of B cell terminal differentiation by environmental contaminant 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol. 2013;268(1):17\u201326. https:\/\/doi.org\/10.1016\/j.taap.2013.01.015","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"7364_CR12","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1124\/mol.53.4.623","volume":"53","author":"CE Sulentic","year":"1998","unstructured":"Sulentic CE, Holsapple MP, Kaminski NE. Aryl hydrocarbon receptor-dependent suppression by 2,3,7,8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells. Mol Pharmacol. 1998;53(4):623\u20139.","journal-title":"Mol Pharmacol"},{"issue":"2","key":"7364_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/toxsci\/kfx215","volume":"161","author":"AK Ehrlich","year":"2018","unstructured":"Ehrlich AK, Pennington JM, Bisson WH, Kolluri SK, Kerkvliet NI. TCDD, FICZ, and other high affinity AhR ligands dose-dependently determine the fate of CD4 T cell differentiation. Toxicol Sci. 2018;161(2):310\u201320. https:\/\/doi.org\/10.1093\/toxsci\/kfx215","journal-title":"Toxicol Sci"},{"key":"7364_CR14","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1146\/annurev-immunol-032713-120245","volume":"32","author":"B Stockinger","year":"2014","unstructured":"Stockinger B, Meglio PD, Gialitakis M, Duarte JH. The Aryl hydrocarbon receptor: multitasking in the immune system. Annu Rev Immunol. 2014;32:403\u201332. https:\/\/doi.org\/10.1146\/annurev-immunol-032713-120245","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"7364_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1084\/jem.20160789","volume":"214","author":"B Vaidyanathan","year":"2017","unstructured":"Vaidyanathan B, Chaudhry A, Yewdell WT, Angeletti D, Yen W, Wheatley AK, et al. The Aryl hydrocarbon receptor controls cell-fate decisions in B cells. J Exp Med. 2017;214(1):197\u2013208. https:\/\/doi.org\/10.1084\/jem.20160789","journal-title":"J Exp Med"},{"issue":"2","key":"7364_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2220\/biomedres.33.67","volume":"33","author":"T Yoshida","year":"2012","unstructured":"Yoshida T, Katsuya K, Oka T, Koizumi S, Wakita D, Kitamura H, Nishimura T. Effects of AhR ligands on the production of Immunoglobulins in purified mouse B cells. Biomed Res. 2012;33(2):67\u201374. https:\/\/doi.org\/10.2220\/biomedres.33.67","journal-title":"Biomed Res"},{"issue":"2","key":"7364_CR17","first-page":"101","volume":"3","author":"LD Notarangelo","year":"1992","unstructured":"Notarangelo LD, Duse M, Ugazio AG. Immunodeficiency with hyper-IgM (HIM). Immunodefic Rev. 1992;3(2):101\u201321.","journal-title":"Immunodefic Rev"},{"issue":"5","key":"7364_CR18","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/s0092-8674(00)00079-9","volume":"102","author":"P Revy","year":"2000","unstructured":"Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell. 2000;102(5):565\u201375. https:\/\/doi.org\/10.1016\/s0092-8674(00)00079-9","journal-title":"Cell"},{"issue":"5","key":"7364_CR19","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/s0092-8674(00)00078-7","volume":"102","author":"M Muramatsu","year":"2000","unstructured":"Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 2000;102(5):553\u201363. https:\/\/doi.org\/10.1016\/s0092-8674(00)00078-7","journal-title":"Cell"},{"issue":"8","key":"7364_CR20","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1002\/art.40877","volume":"71","author":"DM T\u00f3th","year":"2019","unstructured":"T\u00f3th DM, Ocsk\u00f3 T, Balog A, Markovics A, Mikecz K, Kov\u00e1cs L, et al. Amelioration of autoimmune arthritis in mice treated with the DNA methyltransferase inhibitor 5\u2019-azacytidine. Arthritis Rheumatol. 2019;71(8):1265\u201375. https:\/\/doi.org\/10.1002\/art.40877","journal-title":"Arthritis Rheumatol"},{"issue":"7191","key":"7364_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature06880","volume":"453","author":"FJ Quintana","year":"2008","unstructured":"Quintana FJ, Basso AS, Iglesias AH, Korn T, Farez MF, Bettelli E, et al. Control of T reg and T H 17 cell differentiation by the Aryl hydrocarbon receptor. Nature. 2008;453(7191):65. https:\/\/doi.org\/10.1038\/nature06880","journal-title":"Nature"},{"key":"7364_CR22","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLOS Biol. 2020;18:e3000410. https:\/\/doi.org\/10.1371\/journal.pbio.3000410","journal-title":"PLOS Biol"},{"issue":"2","key":"7364_CR23","first-page":"Article8","volume":"7","author":"S Ramos","year":"2019","unstructured":"Ramos S. Does TCDD exposure alter \u03b27-Integrin expression on mouse B cells?? Ursidae: Undergrad Res J Univ North Colo. 2019;7(2):Article8.","journal-title":"Ursidae: Undergrad Res J Univ North Colo"},{"issue":"1","key":"7364_CR24","first-page":"Article3","volume":"10","author":"KM Hufford","year":"2021","unstructured":"Hufford KM, Weaver OD, Young NM, King AE, DeKrey GK. Flow cytometry for identification of PRDM1-eYFP Transgenic mice. Ursidae: Undergrad Res J Univ North Colo. 2021;10(1):Article3.","journal-title":"Ursidae: Undergrad Res J Univ North Colo"},{"key":"7364_CR25","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3724\/abbs.2022070","volume":"54","author":"K Yu","year":"2022","unstructured":"Yu K. AID function in somatic hypermutation and class switch recombination. Acta Biochim Biophys Sin (Shanghai). 2022;54:759\u201366. https:\/\/doi.org\/10.3724\/abbs.2022070","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"4","key":"7364_CR26","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.18632\/oncotarget.1637","volume":"5","author":"UM Litzenburger","year":"2014","unstructured":"Litzenburger UM, Opitz CA, Sahm F, Rauschenbach KJ, Trump S, Winter M, et al. Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR. Oncotarget. 2014;5(4):1038. https:\/\/doi.org\/10.18632\/oncotarget.1637","journal-title":"Oncotarget"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07364-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-025-07364-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07364-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T11:10:40Z","timestamp":1757243440000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-025-07364-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7364"],"URL":"https:\/\/doi.org\/10.1186\/s13104-025-07364-3","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"24 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Institutional Animal Care and Use Committee of the University of Northern Colorado.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"296"}}